The share price of Foghorn Therapeutics Inc. (FHTX) now
Latest session on the 5th of December for
Foghorn Therapeutics Inc. is negative
Trading Volume: 21535
Open: 4.57 /
High: 4.6 /
Low: 4.49
What analysts predict: $14.25
52-week High/Low: $9.97 / $2.84
50/200 Day Moving Average:
$3.986 / $6.26
This figure corresponds to the Average Price over the previous 50/200 days.
For Foghorn Therapeutics stocks, the 50-day moving average is the support level today.
For Foghorn Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Foghorn Therapeutics Inc. stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the Foghorn Therapeutics
stock price in 2024, 2025, 2026, 2027, 2028.
How much will one Foghorn Therapeutics share be worth in
2024 - 2028?
When should I take profit in Foghorn Therapeutics stock?
When should I record a loss on Foghorn Therapeutics stock?
What are analysts' forecasts for Foghorn Therapeutics stock?
What is the future of Foghorn Therapeutics stock?
We forecast Foghorn Therapeutics stock performance using neural networks based on historical data on Foghorn Therapeutics stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Foghorn Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2024, 2025, 2026, 2027 and 2028)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Foghorn Therapeutics shares. This happens once a day.
Historical and forecast chart of Foghorn Therapeutics stock
The chart below shows the historical price of Foghorn Therapeutics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Foghorn Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Foghorn Therapeutics Inc. focuses on the discovery and development of drugs targeting genetically determined addictions in the chromatin regulatory system. The Company’s gene traffic management platform enables it to identify, validate and potentially use drug targets in the chromatin regulatory system. It is initially focused on oncology. The company is developing FHD-286, a selective allosteric ATPase inhibitor, and FHD-609, a protein breaker, for the treatment of hematologic cancers and solid tumors. FHD-286 is an allosteric and orally available, small molecule, enzymatic inhibitor of BRG1 and BRM, which is initially being developed for the treatment of acute myeloid leukemia (AML) and uveal melanoma. FHD-609 is an intravenous, small molecule protein breaker BRD9. The company is also developing complementary programs for large populations, which include selective BRM and selective ARID1B modulators.
Trending Themes in the Healthcare Sector
Foghorn Therapeutics daily forecast for a month
Date
Target
Pes.
Opt.
Vol., %
Dec 08
4.67
4.51
4.79
6.11
Dec 09
4.65
4.58
4.80
4.77
Dec 10
4.52
4.34
4.66
7.50
Dec 11
4.46
4.35
4.57
5.13
Dec 12
4.46
4.37
4.55
4.29
Dec 13
4.46
4.37
4.62
5.61
Dec 14
4.37
4.21
4.48
6.65
Dec 15
4.36
4.30
4.45
3.29
Dec 16
4.19
4.07
4.26
4.79
Dec 17
4.24
4.12
4.38
6.32
Dec 18
4.27
4.15
4.33
4.27
Dec 19
4.20
4.14
4.31
4.00
Dec 20
4.26
4.16
4.34
4.15
Dec 21
4.43
4.38
4.49
2.48
Dec 22
4.60
4.45
4.71
5.94
Dec 23
4.79
4.60
4.88
6.20
Dec 24
4.90
4.84
5.01
3.44
Dec 25
5.03
4.84
5.12
5.82
Dec 26
4.98
4.87
5.04
3.53
Dec 27
4.92
4.85
5.04
3.96
Dec 28
4.91
4.72
5.04
6.77
Dec 29
5.03
4.88
5.21
6.81
Dec 30
4.93
4.74
5.06
6.86
Dec 31
5.01
4.86
5.16
6.34
Jan 01
4.93
4.77
5.08
6.63
Jan 02
4.94
4.81
5.13
6.73
Jan 03
4.97
4.82
5.16
6.96
Jan 04
4.89
4.84
4.95
2.12
Jan 05
4.95
4.80
5.00
4.23
Jan 06
4.79
4.71
4.93
4.67
Foghorn Therapeutics Daily Price Targets
Foghorn Therapeutics Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $4.67. Positive dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 5.762%. Pessimistic target level: 4.51 Optimistic target level: 4.79
Foghorn Therapeutics Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $4.65. Negative dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 4.557%. Pessimistic target level: 4.58 Optimistic target level: 4.80
Foghorn Therapeutics Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $4.52. Negative dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 6.973%. Pessimistic target level: 4.34 Optimistic target level: 4.66
Foghorn Therapeutics Stock Forecast 12-11-2023.
Forecast target price for 12-11-2023: $4.46. Negative dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 4.876%. Pessimistic target level: 4.35 Optimistic target level: 4.57
Foghorn Therapeutics Stock Forecast 12-12-2023.
Forecast target price for 12-12-2023: $4.46. Negative dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 4.114%. Pessimistic target level: 4.37 Optimistic target level: 4.55
Foghorn Therapeutics Stock Forecast 12-13-2023.
Forecast target price for 12-13-2023: $4.46. Negative dynamics for Foghorn Therapeutics shares will prevail with possible volatility of 5.309%. Pessimistic target level: 4.37 Optimistic target level: 4.62
500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, US
Market Capitalization:
189 099 000 $
Market capitalization of the Foghorn Therapeutics Inc. is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of FHTX shares in the company outstanding by the market price of one share.
EBITDA:
-110 887 000 $
EBITDA of Foghorn Therapeutics is earnings before interest, income tax and depreciation of assets.
PE Ratio:
None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
None
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
-2.46
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
N/A
Quarterly Revenue Growth YOY:
1.635
Trailing PE:
-
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
-
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
2.963
Enterprise Value (EV) /Revenue
EV To EBITDA:
0.227
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
42217100
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website